BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9588898)

  • 1. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
    Visonneau S; Cesano A; Torosian MH; Miller EJ; Santoli D
    Am J Pathol; 1998 May; 152(5):1299-311. PubMed ID: 9588898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
    Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
    Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice.
    Visonneau S; Cesano A; Torosian MH; Santoli D
    Clin Cancer Res; 1997 Sep; 3(9):1491-500. PubMed ID: 9815835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
    Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice.
    Huang P; Allam A; Taghian A; Freeman J; Duffy M; Suit HD
    J Neurosurg; 1995 Aug; 83(2):308-15. PubMed ID: 7616277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis.
    Endo M; Yamamoto Y; Nakano M; Masuda T; Odagiri H; Horiguchi H; Miyata K; Kadomatsu T; Motokawa I; Okada S; Iwase H; Oike Y
    Int J Biol Markers; 2014 Sep; 29(3):e239-45. PubMed ID: 24585434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nod Scid mouse model to study human prostate cancer.
    Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
    Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
    Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
    Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
    Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
    Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
    Kutasovic JR; McCart Reed AE; Males R; Sim S; Saunus JM; Dalley A; McEvoy CR; Dedina L; Miller G; Peyton S; Reid L; Lal S; Niland C; Ferguson K; Fellowes AP; Al-Ejeh F; Lakhani SR; Cummings MC; Simpson PT
    J Pathol Clin Res; 2019 Jan; 5(1):25-39. PubMed ID: 30246500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.
    Beckhove P; Schütz F; Diel IJ; Solomayer EF; Bastert G; Foerster J; Feuerer M; Bai L; Sinn HP; Umansky V; Schirrmacher V
    Int J Cancer; 2003 Jul; 105(4):444-53. PubMed ID: 12712433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of BRCA1 and p16 gene methylation in sporadic breast cancer].
    Feng J; Hu LH; Lu J; Li YR; Xie F
    Ai Zheng; 2009 Apr; 28(4):436-40. PubMed ID: 19622308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
    Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
    Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
    Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
    Sansone P; Ceccarelli C; Berishaj M; Chang Q; Rajasekhar VK; Perna F; Bowman RL; Vidone M; Daly L; Nnoli J; Santini D; Taffurelli M; Shih NN; Feldman M; Mao JJ; Colameco C; Chen J; DeMichele A; Fabbri N; Healey JH; Cricca M; Gasparre G; Lyden D; Bonafé M; Bromberg J
    Nat Commun; 2016 Feb; 7():10442. PubMed ID: 26858125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
    Jansson M; Billing O; Herdenberg C; Lundin C; Tolockiene E; Nazemroaya A; Sund M
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):69-77. PubMed ID: 32124140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human bone NOD/SCID mouse model to distinguish metastatic potential in primary breast cancers.
    Lam P; Yang W; Amemiya Y; Kahn H; Yee A; Holloway C; Seth A
    Cancer Biol Ther; 2009 Jun; 8(11):1010-7. PubMed ID: 19398888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.